Keith A. Jones

VP Finance, US Business Controller at Stemline Therapeutics

Keith A. Jones has extensive experience in financial planning, analysis, and management reporting in the pharmaceutical industry. Keith A. currently holds the position of Vice President Financial Planning at Stemline Therapeutics, where they serve as a business partner to the c-suite and department heads, leading short and long-range planning activities for global activities across multiple entities.

Prior to their current role, Jones worked at Ovid Therapeutics as a Senior Director Financial Planning, Analysis & Procurement. In this position, they led financial planning, analysis, and sourcing functions and provided analytical and decision support to the C-suite. Keith A. also partnered with Contract Research Organizations (CROs) on financial accruals and risk management.

Before joining Ovid Therapeutics, Jones held the position of Director Financial Planning Analysis at the same company from 2016 to 2018. In this role, they managed financial planning, analysis, and management reporting, establishing the clinical trial forecasting and accrual process. Keith A. also served as a financial and procurement partner for various functions within the organization.

Prior to Ovid Therapeutics, Jones worked at Novartis for several years. Keith A. held the role of Assoc. Director - Financial Planning & Analysis, providing financial planning and analysis support for brand marketing spend within the Cardio/Resp division. Keith A. also served as the Manager, Financial Planning & Systems at Novartis, co-leading system design, implementation, and change management projects.

Jones began their career at Bristol-Myers Squibb, where they held various positions over the span of more than a decade. Keith A. started as an Accounting Clerk and progressed to roles such as Senior Financial Analyst, Principal Financial Analyst, and Manager, Financial Systems & Analysis. In their role as Manager, they led a team responsible for the system administration and operation of a cross-divisional financial systems portfolio.

Throughout their career, Keith A. Jones has demonstrated expertise in financial planning, analysis, and management reporting in the pharmaceutical industry, partnering with various departments and contributing to the success of the organizations they have worked for.

Keith A. Jones pursued their education at Southern New Hampshire University from 2012 to 2015, where they obtained a Bachelor's degree in Business Studies with a focus on Accounting. Additionally, in April 2022, they achieved a certification in Using Power BI with Excel (2019) from LinkedIn.

Links

Previous companies

Ovid Therapeutics logo
Novartis logo
Bristol-Myers Squibb logo

Timeline

  • VP Finance, US Business Controller

    April 1, 2024 - present

  • Vice President Financial Planning

    May, 2022